Abstract
In this study, gas chromatography mass spectrometry (GC-MS) and two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC-TOFMS) were employed for the metabolic footprinting of a pair of immortalized human uroepithelial cells namely HUC-1 (nontumorigenic) and HUC T-2 (tumorigenic). Both HUC-1 and HUC T-2 cell lines were cultivated in 1 mL of Ham’s F-12 media. Subsequent to 48 h of incubation, 200 μL of cell culture supernatant was protein-precipitated using 1.7 mL of methanol and an aliquot of 1.5 mL of the mixture was separated, dried, trimethylsilyl-derivatized, and analyzed using GC-MS and GC×GC-TOFMS. Metabolic profiles were analyzed using multivariate data analysis techniques to evaluate the changes of the metabolomes. Both GC-MS and GC×GC-TOFMS analyses showed distinct differences in metabolic phenotypes of the normal and tumorigenic human bladder cells (partial least squares-discriminant analysis (PLS-DA) of GC×GC-TOFMS data; two latent variables, R 2 X = 0.418, R 2 Y = 0.977 and Q 2 (cumulative) = 0.852). Twenty metabolites were identified as being statistically different between the two cell types. These metabolites revealed that several key metabolic pathways were perturbed in tumorigenic urothelial cells as compared to the normal cells. Application of GC×GC-TOFMS offered several advantages compared to classical one-dimensional GC-MS which include enhanced chromatographic resolution (without increase in analytical run time), increase in sensitivity, improved identification of metabolites, and also separation of reagent artifacts from the metabolite peaks. Our results reinforced the advantages of GC×GC-TOFMS and the role of metabolomics in characterizing bladder cancer biology using in vitro cell culture models.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) CA Cancer J Clin 59:225–249
Lotan Y, Roehrborn CG (2002) J Urol 167:75–79
Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG (2005) Nat Rev Microbiol 3:557–565
Mapelli V, Olsson L, Nielsen J (2008) Trends Biotechnol 26:490–497
Kaderbhai NN, Broadhurst DI, Ellis DI, Goodacre R, Kell DB (2003) Comp Funct Genomics 4:376–391
Fiehn O (2002) Plant Mol Biol 48:155–171
Buchholz A, Hurlebaus J, Wandrey C, Takors R (2002) Biomol Eng 19:5–15
Villas-Boas SG, Noel S, Lane GA, Attwood G, Cookson A (2006) Anal Biochem 349:297–305
Abel CB, Lindon JC, Noble D, Rudd BA, Sidebottom PJ, Nicholson JK (1999) Anal Biochem 270:220–230
Miccheli AT, Miccheli A, Di Clemente R, Valerio M, Coluccia P, Bizzarri M, Conti F (2006) Biochim Biophys Acta 1760:1723–1731
Dunn WB, Brown M, Worton SA, Crocker IP, Broadhurst D, Horgan R, Kenny LC, Baker PN, Kell DB, Heazell AE (2009) Placenta 30:974–980
Pope GA, MacKenzie DA, Defernez M, Aroso MA, Fuller LJ, Mellon FA, Dunn WB, Brown M, Goodacre R, Kell DB, Marvin ME, Louis EJ, Roberts IN (2007) Yeast 24:667–679
Pasikanti KK, Ho PC, Chan EC (2008) J Chromatogr B Analyt Technol Biomed Life Sci 871:202–211
Want EJ, Nordstrom A, Morita H, Siuzdak G (2007) J Proteome Res 6:459–468
Almstetter MF, Appel IJ, Gruber MA, Lottaz C, Timischl B, Spang R, Dettmer K, Oefner PJ (2009) Anal Chem 81:5731–5739
Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, Yu Y, Xu G (2009) Anal Chim Acta 633:257–262
Ralston-Hooper K, Hopf A, Oh C, Zhang X, Adamec J, Sepulveda MS (2008) Aquat Toxicol 88:48–52
Mohler RE, Dombek KM, Hoggard JC, Pierce KM, Young ET, Synovec RE (2007) Analyst 132:756–767
Shellie RA, Welthagen W, Zrostlikova J, Spranger J, Ristow M, Fiehn O, Zimmermann R (2005) J Chromatogr A 1086:83–90
Cortes HJ, Winniford B, Luong J, Pursch M (2009) J Sep Sci 32:883–904
Ong RC, Marriott PJ (2002) J Chromatogr Sci 40:276–291
Welthagen W, Shellie RA, Spranger J, Ristow M, Zimmermann R, Fiehn O (2005) Metabolomics 1:65–73
Kopka J, Schauer N, Krueger S, Birkemeyer C, Usadel B, Bergmuller E, Dormann P, Weckwerth W, Gibon Y, Stitt M, Willmitzer L, Fernie AR, Steinhauser D (2005) Bioinformatics 21:1635–1638
Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, Weljie AM, Dowlatabadi R, Bamforth F, Clive D, Greiner R, Li L, Marrie T, Sykes BD, Vogel HJ, Querengesser L (2007) Nucleic Acids Res 35:D521–D526
Mendes P (2002) Brief Bioinform 3:134–145
Pasikanti KK, Ho PC, Chan EC (2008) Rapid Commun Mass Spectrom 22:2984–2992
Koek MM, Muilwijk B, van Stee LL, Hankemeier T (2008) J Chromatogr A 1186:420–429
Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan EC (2010) J Proteome Res 9:2988–2995
Dalluge J, Beens J, Brinkman UA (2003) J Chromatogr A 1000:69–108
Donato P, Tranchida PQ, Dugo P, Dugo G, Mondello L (2007) J Sep Sci 30:508–526
Ong R, Marriott P, Morrison P, Haglund P (2002) J Chromatogr A 962:135–152
Begley P, Francis-McIntyre S, Dunn WB, Broadhurst DI, Halsall A, Tseng A, Knowles J, Goodacre R, Kell DB (2009) Anal Chem 81:7038–7046
Oh C, Huang X, Regnier FE, Buck C, Zhang X (2008) J Chromatogr A 1179:205–215
Holmes E, Antti H (2002) Analyst 127:1549–1557
Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J (2008) Anal Chem 80:115–122
Trygg J, Holmes E, Lundstedt T (2007) J Proteome Res 6:469–479
Theodoropoulos VE, Lazaris A, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, Manikas K, Kastriotis I (2004) Eur Urol 46:200–208
Ioachim E, Michael M, Salmas M, Michael MM, Stavropoulos NE, Malamou-Mitsi V (2006) Urol Int 77:255–263
Griffin JL, Shockcor JP (2004) Nat Rev Cancer 4:551–561
Dang CV, Semenza GL (1999) Trends Biochem Sci 24:68–72
Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH (2002) Biochim Biophys Acta 1555:14–20
Acknowledgments of research support
This study was supported by the National University of Singapore (NUS) grant R-148-000-100-112 provided to E.C.Y.C and National Medical Research Council grant R-176-000-119-213 provided to K.E., P.C.H., R.M., and E.C.Y.C. GC × GC-TOFMS was kindly sponsored by the NUS grant R-279-000-249-646. K.K.P is supported by NUS President's Graduate Fellowship.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 675 kb)
Rights and permissions
About this article
Cite this article
Pasikanti, K.K., Norasmara, J., Cai, S. et al. Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry. Anal Bioanal Chem 398, 1285–1293 (2010). https://doi.org/10.1007/s00216-010-4055-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4055-3